Healthcare sector earnings set to pick up pace


Malaysia is expected to receive its first batch of one million doses of the Pfizer Inc/BioNTech Covid-19 vaccine in February 2021 and AmInvestment believed that the first batch of vaccines would be administered in Q2 or Q3 this year.

PETALING JAYA: With the roll-out of the Covid-19 vaccines on the horizon, earnings prospects for the healthcare sector are looking positive not just for the short-term but also for the longer period on higher demand.

Although recovery in inpatient volume is only expected to be modest in 2021, AmInvestment Bank said earnings are set to pick up due to potential public-private collaborations, improved margins as a result of cost-cutting measures and a focus on low capex and gestational period projects.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Healthcare , earnings , AstraZeneca , Pfizer , Biontech , Duopharma , KPI ,

Next In Business News

The power of AI�
Leaving the dollar a thorny issue
Raising the bar for Bursa�
Value for your ringgit
Ringgit to trade around RM4.07-4.08 with upside bias next week, supported by stronger 2Q GDP
Sime Darby Property tops off RM299mil Kanopi Residences at Elmina City Centre
Eco homes vs changing climate
NHP 2026–2035: Bold vision requires BTS
Fads in condo facilities: What’s fading?
Distorted valuation methods hide true value

Others Also Read